Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC) (original) (raw)
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study
Angela Spanu
Diagnostics, 2021
View PDFchevron_right
Can 18F-fluorodeoxyglucose positron emission tomography predict the response to radioactive iodine therapy in metastatic differentiated thyroid carcinoma?
anu bhattarai
View PDFchevron_right
2-[18F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study
Alberto Miceli
Diagnostics, 2022
View PDFchevron_right
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy
Michele Klain
Medicine, 2017
View PDFchevron_right
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer
James Mountz
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007
View PDFchevron_right
IMAGING IN ENDOCRINOLOGY: 18F-FDG PET/CT in differentiated thyroid carcinoma: clinical indications and controversies in the diagnosis and follow- up of differentiated thyroid cancer
Bernadette Biondi
European journal of endocrinology / European Federation of Endocrine Societies, 2015
View PDFchevron_right
The Added Clinical Value of 18F-FDG PET/CT in Evaluating Intratracheal Recurrence of Differentiated Thyroid Carcinoma: Implications for Planning Surgery, Assessing Its Completeness, and Planning Radioiodine Therapy
Amit Abhyankar
Journal of Nuclear Medicine Technology, 2013
View PDFchevron_right
Dose-response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT
Felix Mottaghy
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016
View PDFchevron_right
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?
Francesco Giammarile
European Journal of Endocrinology, 2003
View PDFchevron_right
Low FDG Metabolic Activity of Loco-Regional Recurrence in Thyroid Cancer Patients; Is Iodine-131 has a Potentiality?
Esraa Ahmed
The Open Nuclear Medicine Journal, 2014
View PDFchevron_right
Diagnostic Management of Suspected Metastatic Thyroid Carcinoma. A Comparative study of Octreotide, dedicated and non-dedicated PET FDG Scans in Patients with Negative High Dose Radioiodine Scan
Francesco Giammarile
View PDFchevron_right
FDG PET Performed at Thyroid Remnant Ablation Has a Higher Predictive Value for Long-Term Survival of High-Risk Patients With Well-Differentiated Thyroid Cancer Than Radioiodine Uptake
Nagara Tamaki
Clinical nuclear medicine, 2015
View PDFchevron_right
PET imaging in differentiated thyroid cancer: where does it fit and how do we use it?
Richard Kloos
Arquivos Brasileiros de Endocrinologia & Metabologia, 2007
View PDFchevron_right
Comparison of simultaneous 18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer
Carlo Cavaliere
European Journal of Nuclear Medicine and Molecular Imaging, 2020
View PDFchevron_right
IMAGING IN ENDOCRINOLOGY: 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up
Bernadette Biondi
European journal of endocrinology, 2015
View PDFchevron_right
Head-to-head comparison of F-18 FDG PET/CT in radioidine refractory thyroid cancer patients with elevated versus suppressed TSH levels a pilot study
Santiago Almeida
Heliyon, 2020
View PDFchevron_right
18F-FDG PET/CT in Differentiated Thyroid Carcinoma
D. Piciu
Acta Endocrinologica (Bucharest), 2019
View PDFchevron_right
Early Predictive Response to Multi-Tyrosine Kinase Inhibitors in Advanced Refractory Radioactive-Iodine Differentiated Thyroid Cancer: A New Challenge for [18F]FDG PET/CT
Giulia Santo
Diagnostics
View PDFchevron_right
[18F]-2-Fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic 131I whole body scans and …
Steven Larson
Journal of Clinical …, 1999
View PDFchevron_right
Prognostic Value of FDG PET/CT in Differentiated Thyroid Cancer Patients
khaled elsaban
The Egyptian Journal of Hospital Medicine
View PDFchevron_right
Prognostic Role of 2-[18F]FDG PET/CT Metabolic Volume Parameters in Patients Affected by Differentiated Thyroid Carcinoma with High Thyroglobulin Level, Negative 131I WBS and Positive 2-[18F]-FDG PET/CT
Carlo Rodella
Diagnostics
View PDFchevron_right
18F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study
Giovanni Frezza
Journal of thyroid research, 2017
View PDFchevron_right
FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma
Seo Young Kang
PLOS ONE
View PDFchevron_right
Assessment of lesion response in the initial radioiodine treatment of differentiated thyroid cancer using 124I PET imaging
Walter Jentzen
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014
View PDFchevron_right
Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET
Andreas Bockisch
European Journal of Nuclear Medicine and Molecular Imaging, 2008
View PDFchevron_right
Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[ 18 F]Fluoro-2-Deoxy- d -Glucose-Positron Emission Tomography Scanning
Steven Larson
The Journal of Clinical Endocrinology & Metabolism, 2006
View PDFchevron_right
Histopathologic Characterization of Radioactive Iodine-Refractory Fluorodeoxyglucose-Positron Emission Tomography-Positive Thyroid Carcinoma
Daniel Gomez
Cancer, 2008
View PDFchevron_right
18F-FDG uptake as a prognostic variable in primary differentiated thyroid cancer incidentally detected by PET/CT: a multicentre study
Fabio Orlandi
European Journal of Nuclear Medicine and Molecular Imaging, 2014
View PDFchevron_right
Recurrent differentiated thyroid cancer: towards personalized treatment based on evaluation of tumor characteristics with PET (THYROPET Study): study protocol of a multicenter observational cohort study
Laura Terry
BMC Cancer, 2014
View PDFchevron_right
Diagnostic Accuracy and Prognostic Value of 18F-FDG PET in Hürthle Cell Thyroid Cancer Patients
Heiko Schoder
Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2006
View PDFchevron_right
Role of 18F-FDG PET and PET/CT imaging in thyroid cancer
Stefano Fanti
Biomedicine & Pharmacotherapy, 2006
View PDFchevron_right
Preoperative Diagnostic Value of [18F] Fluorodeoxyglucose Positron Emission Tomography in Patients With Radioiodine-Negative Recurrent Well-Differentiated Thyroid Carcinoma
R. Görges
Annals of Surgery, 2001
View PDFchevron_right